The risk of latent tuberculosis infection in patients with type 2 diabetes mellitus according to the use of sodium-glucose cotransporter 2 inhibitors: A national database cohort study
SGLT2-i might reduce the risk of LTBI in patients with new-onset DM in a dose-response manner. Although validation of this possibility is needed, using SGLT2-i in patients with DM might be considered in the absence of contraindications.
Authors
- Yu-Cih Wu
- Chung-Shu Lee (ORCID: https://orcid.org/0000-0003-0466-7796)
- Kung-Ming Laio
- Chung-Han Ho
Institutions
- Taipei Medical University Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- National Taiwan University Hospital (TW)
- Chi Mei Medical Center (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1016/j.ijid.2026.108436
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00